Headquarters
850 N 5TH ST STE 545, PHOENIX, AZ 85004-2289, US
PHOENIX, AZ, US
From the company
FAKnostics is a biopharmaceutical company developing therapeutics and diagnostics based on its Focal Adhesion Kinase (FAK) platform technology to combat metastatic cancers and fibrosis. Its proprietary hydrocarbon-stapled peptide FN-2012 blocks the FAK FAT domain, and its FAKnosTEST companion diagnostic detects cancer in early stages. The company reports more than 30 years of FAK research leadership and has 3 pre-clinical programs in fibrotic diseases.
850 N 5TH ST STE 545, PHOENIX, AZ 85004-2289, US
Quantities, certifications, and timing.